Gedurende de post-marketingperiode zijn de volgende ernstige bijwerkingen gerapporteerd: ###>Serious adverse reactions reported during the post-marketing period include: – Arterial thrombotic events such as myocardial infarctions or ischaemia, cerebrovascular disorders and bowel infarction.